Table 3.
a. Private-sector retail pharmacies [N = 30] | |||
Insulin type and delivery device | Company Type | ||
Indian | Non-Indian | Combined (Indian & Non-Indian) | |
Human insulin (overall) | 73.3% (n = 22) | 96.7% (n = 29) | 96.7% (n = 29) |
Vial | |||
40 IU/ml | 66.7% (n = 20) | 96.7% (n = 29) | 96.7% (n = 29) |
100 IU/ml | 50.0% (n = 15) | 43.3% (n = 13) | 66.7% (n = 20) |
Cartridge | |||
40 IU/ml | 0.0% (n = 0) | 0.0% (n = 0) | 0.0% (n = 0) |
100 IU/ml | 0.0% (n = 0) | 30.0% (n = 9) | 30.0% (n = 9) |
Pen | |||
40 IU/ml | 0.0% (n = 0) | 0.0% (n = 0) | 0.0% (n = 0) |
100 IU/ml | 0.0% (n = 0) | 36.6% (n = 11) | 36.7% (n = 11) |
Analogue insulin (overall) | 26.7% (n = 8) | 76.7% (n = 23) | 80.0% (n = 24) |
Vial | |||
40 IU/ml | 0.0% (n = 0) | 0.0% (n = 0) | 0.0% (n = 0) |
100 IU/ml | 20.0% (n = 6) | 0.0% (n = 0) | 20.0% (n = 6) |
Cartridge | |||
40 IU/ml | 0.0% (n = 0) | 0.0% (n = 0) | 0.0% (n = 0) |
100 IU/ml | 10.0% (n = 3) | 30.0% (n = 9) | 33.3% (n = 10) |
Pen | |||
40 IU/ml | 0.0% (n = 0) | 0.0% (n = 0) | 0.0% (n = 0) |
100 IU/ml | 0.0% (n = 0) | 73.3% (n = 22) | 73.3% (n = 22) |
b. Public-sector hospital pharmacies [N = 5] | |||
Human insulin (overall) | 80.0% (n = 4) | 60.0% (n = 3) | 80.0% (n = 4) |
Vial | |||
40 IU/ml | 80.0% (n = 4) | 60.0% (n = 3) | 80.0% (n = 4) |
100 IU/ml | 60.0% (n = 3) | 20.0% (n = 1) | 60.0% (n = 3) |
Cartridge | |||
100 IU/ml | 0.0% (n = 0) | 20.0% (n = 1) | 20.0% (n = 1) |
Pen | |||
100 IU/ml | 0.0% (n = 0) | 20.0% (n = 1) | 20.0% (n = 1) |
Analogue insulin (overall) | 40.0% (n = 2) | 40.0% (n = 2) | 60.0% (n = 3) |
Vial | |||
40 IU/ml | 0.0% (n = 0) | 0.0% (n = 0) | 0.0% (n = 0) |
100 IU/ml | 40.0% (n = 2) | 0.0% (n = 0) | 40.0% (n = 2) |
Cartridge | |||
100 IU/ml | 0.0% (n = 0) | 20.0% (n = 1) | 20.0% (n = 1) |
Pen | |||
100 IU/ml | 0.0% (n = 0) | 40.0% (n = 2) | 40.0% (n = 2) |